LoginSignup
Illumina logo

Illumina

Stock
Stock
ISIN: US4523271090
Ticker: ILMN
US4523271090
ILMN

Price

Price

Frequently asked questions

What is Illumina's market capitalization?

The market capitalization of Illumina is $21.73B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Illumina?

Illumina's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$9.997. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Illumina's stock?

Currently, 23 analysts cover Illumina's stock, with a consensus target price of $148.71. Analyst ratings provide insights into the stock's expected performance.

What is Illumina's revenue over the trailing twelve months?

Over the trailing twelve months, Illumina reported a revenue of $4.39B.

What is the EBITDA for Illumina?

Illumina's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $738.00M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Illumina?

Illumina has a free cash flow of $547.00M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Illumina's stock?

The 5-year beta for Illumina is 1.11. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Illumina have, and what sector and industry does it belong to?

Illumina employs approximately 10,590 people. It operates in the Health Care sector, specifically within the Scientific & Technical Instr. industry.

What is the free float of Illumina's shares?

The free float of Illumina is 158.16M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $21.73B

5Y beta

 1.11

EPS (TTM)

 -$9.997

Free Float

 158.16M

Revenue (TTM)

 $4.39B

EBITDA (TTM)

 $738.00M

Free Cashflow (TTM)

 $547.00M

Pricing

1D span
$135.54$138.10
52W span
$90.88$156.66

Analyst Ratings

The price target is $148.71 and the stock is covered by 23 analysts.

Buy

10

Hold

11

Sell

2

Information

Illumina, Inc. is engaged in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Its products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its product categories include Instruments, Kits & Reagents, Selection Tools, and Software & Analysis. Its Instruments category include sequencing platforms, microarray scanners, and IVD instruments. Its Kits & Reagents category consists of library preparation kits, sequencing reagents, microarray kits, clinical research products, and IVD products. Its Selection Tools category include Library Prep & Array Kit Selector, Gene Panel & Array Finder, DesignStudio Custom Assay Designer, and other. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training. It is also a developer of an emerging and highly differentiated single-cell technology.

10,590

Scientific & Technical Instr.

Health Care

Identifier

ISIN

US4523271090

Primary Ticker

ILMN

Knockouts

Join the conversation
Sign upLogin